BIOSTAR PHARM-B (02563) suggests adopting a stock ownership plan.
Huahao Zhongtian Pharmaceuticals-B (02563) announced that on May 6, 2026, the board of directors decided to adopt a stock option plan in accordance with Chapter 17 of the listing rules, to provide incentives or rewards to participants for their contributions or potential contributions to the growth and development of the group.
BIOSTAR PHARM-B (02563) announced that on May 6, 2026, the Board of Directors decided to adopt a stock purchase plan in accordance with Chapter 17 of the Listing Rules, providing incentives or rewards to participants for their contributions or potential contributions to the growth and development of the group.
Related Articles
US Stock Market Move | Concept stocks of encrypted currencies fell, Circle (CRCL.US) fell more than 6%.
US Stock Market Move | Qualcomm (QCOM.US) surged more than 7% in early trading, a 65% increase from its low point in April.
PE ratio of only 10 times vs EPS growth of 327%: Why is Micron (MU. US) still attractive after its big rise?
US Stock Market Move | Concept stocks of encrypted currencies fell, Circle (CRCL.US) fell more than 6%.
US Stock Market Move | Qualcomm (QCOM.US) surged more than 7% in early trading, a 65% increase from its low point in April.
PE ratio of only 10 times vs EPS growth of 327%: Why is Micron (MU. US) still attractive after its big rise?
